Biliary tract carcinoma Hepatocellular carcinoma Pancreas cancer
Conditions
Interventions
None listed
Sponsors
Nagoya university Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who fulfilled the criteria and agreed with the enrollment in this study
Exclusion criteria
Exclusion criteria: Patients who reject to be enrolled in this study Patients who do not fulfill the criteria of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FDP D dimer fibrinogen PT APTT platelet PIC TAT ADAMTS13 factor7 factor13 VWF | — |
Secondary
| Measure | Time frame |
|---|---|
| intra-operative bleeding volume of transfusion operation time blood examination | — |
Countries
Japan
Outcome results
None listed